Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

WithdrawnPhase 1/2

NCT02228512

Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas

Background: \- The chemotherapy combination DA-EPOCH-RP includes the drugs etoposide (E), prednisone (P), vincristine (O), cyclophosphamide (C), doxorubicin (H…

Location not specified0Started 2014-08-15

Treatment: Pomalidomide, Rituximab